The study, carried out by dermatologist Dr April Armstrong of the University of California using data from the National Psoriasis Foundation, showed that 91% of people whose wellbeing has been affected with psoriasis and psoriatic arthritis are covered by some type of private or public health insurance, but the majority spent more than $2,500 per year in out-of-pocket costs for their disease.
The study also found that 22% of psoriasis patients consult their primary care physician rather than a specialist who could fully assess their disease and prescribe the latest treatments, and giving up on treatment and prohibitive costs were cited as primary reasons for those who didn’t seek care, at 28% and 21% respectively. This is a major wellness concern because, if left untreated, psoriatic arthritis can cause irreversible joint damage.
Randy Beranek, National Psoriasis Foundation president and CEO, explained, ‘Unfortunately, co-payments for biologics and phototherapy, two commonly prescribed treatment methods for psoriasis and psoriatic arthritis, can be upwards of $600 per month. We are working with state lawmakers and insurance companies to help lower these costs and remove other barriers that limit access to care.’
When it came to who was more likely to see a specialist for help with the disease, the study showed that people with access to insurance and those with severe psoriasis were significantly ahead of other sub groups in this area. In terms of gender, women were 1.5 times more likely than men to seek care.
Beranek concluded, ‘Psoriasis and psoriatic arthritis are serious systemic diseases that are associated with heart disease, heart attack, diabetes, obesity and depression. Studies show that treating psoriasis can actually reduce risk of some of these other health conditions. Therefore, we must ensure that everyone with psoriatic diseases has access to the treatments they need.’